Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 3
1978 8
1979 1
1981 3
1982 2
1983 1
1984 1
1985 4
1986 1
1987 1
1991 1
1994 1
1996 1
1997 3
1999 1
2001 1
2002 1
2003 4
2004 7
2005 7
2006 3
2007 5
2008 8
2009 9
2010 9
2011 8
2012 8
2013 11
2014 10
2015 8
2016 9
2017 6
2018 11
2019 9
2020 13
2021 29
2022 23
2023 22
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
The impact of higher protein dosing on outcomes in critically ill patients with acute kidney injury: a post hoc analysis of the EFFORT protein trial.
Stoppe C, Patel JJ, Zarbock A, Lee ZY, Rice TW, Mafrici B, Wehner R, Chan MHM, Lai PCK, MacEachern K, Myrianthefs P, Tsigou E, Ortiz-Reyes L, Jiang X, Day AG, Hasan MS, Meybohm P, Ke L, Heyland DK. Stoppe C, et al. Among authors: lai pck. Crit Care. 2023 Oct 18;27(1):399. doi: 10.1186/s13054-023-04663-8. Crit Care. 2023. PMID: 37853490 Free PMC article. Clinical Trial.
Physical activity in relation to urban environments in 14 cities worldwide: a cross-sectional study.
Sallis JF, Cerin E, Conway TL, Adams MA, Frank LD, Pratt M, Salvo D, Schipperijn J, Smith G, Cain KL, Davey R, Kerr J, Lai PC, Mitáš J, Reis R, Sarmiento OL, Schofield G, Troelsen J, Van Dyck D, De Bourdeaudhuij I, Owen N. Sallis JF, et al. Among authors: lai pc. Lancet. 2016 May 28;387(10034):2207-17. doi: 10.1016/S0140-6736(15)01284-2. Epub 2016 Apr 1. Lancet. 2016. PMID: 27045735 Free PMC article.
Cell therapy in vascularized composite allotransplantation.
Anggelia MR, Cheng HY, Lai PC, Hsieh YH, Lin CH, Lin CH. Anggelia MR, et al. Among authors: lai pc. Biomed J. 2022 Jun;45(3):454-464. doi: 10.1016/j.bj.2022.01.005. Epub 2022 Jan 15. Biomed J. 2022. PMID: 35042019 Free PMC article. Review.
Do We Need to Administer Fludrocortisone in Addition to Hydrocortisone in Adult Patients With Septic Shock? An Updated Systematic Review With Bayesian Network Meta-Analysis of Randomized Controlled Trials and an Observational Study With Target Trial Emulation.
Lai PC, Lai CH, Lai EC, Huang YT. Lai PC, et al. Crit Care Med. 2024 Apr 1;52(4):e193-e202. doi: 10.1097/CCM.0000000000006161. Epub 2023 Dec 29. Crit Care Med. 2024. PMID: 38156911 Free PMC article.
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy.
Tam FWK, Tumlin J, Barratt J, Rovin BH, Roberts ISD, Roufosse C, Cook HT, Bhangal G, Brown AL, Busch M, Dudhiya F, Duliege AM, Fraser DJ, Gale DP, Huang CC, Lai PC, Lee M, Masuda ES, McAdoo SP, Rosenkranz AR, Sommerer C, Sunder-Plassmann G, Szeto CC, Tang SCW, Williamson DE, Willcocks L, Vielhauer V, Kim MJ, Todd L, Zayed H, Tong-Starksen S, Lafayette R. Tam FWK, et al. Among authors: lai pc. Kidney Int Rep. 2023 Sep 30;8(12):2546-2556. doi: 10.1016/j.ekir.2023.09.024. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106605 Free PMC article.
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.
Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, Pérez Valdivia MÁ, Wu MS, Susan Huang SH, Alamartine E, Kim SG, Yee M, Kateifides A, Rice K, Garlo K, Barratt J; SANCTUARY Study Investigators. Lafayette R, et al. J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000534. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39455063 No abstract available.
248 results